Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
- PMID: 32283237
- PMCID: PMC7146719
- DOI: 10.1016/j.jaad.2020.04.017
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
Comment in
-
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.Dermatol Ther. 2020 Jul;33(4):e13565. doi: 10.1111/dth.13565. Epub 2020 May 26. Dermatol Ther. 2020. PMID: 32401410 Free PMC article. No abstract available.
References
-
- Lv C., Liu W., Wang B., et al. Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo. Antiviral Res. 2018;159:55–62. - PubMed
-
- Sanz-Navarro J., Feal C., Dauden E. Treatment of human scabies with oral ivermectin. eczematous eruptions as a new non-reported adverse event. Actas Dermosifiliogr. 2017;108(7):643–649. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical